MK Moshe Feiglin: Progress on Sarel Corruption Case
The Yediot Aharonot newspaper reported on Sunday that the Sarel Medical Company is about to lose its monopoly on supplying drugs to Israel’s government hospitals. “The Sarel Company is actually a sophisticated tool for transferring funds from the Health Ministry to the private bank accounts of all sorts of people who know the right people,” said MK Moshe Feiglin. “The government money redirected to private hands is enough to cover the entire deficit of the Health Ministry.”
“When the CEO of Sarel called upon me to remove my Knesset immunity so that he could sue me for slander for revealing the above,” Feiglin added, “ I announced that I would be pleased to do so – on the condition that the company would release all the relevant documents. I haven’t heard from them since.”
“Clearly, the system is in no rush to kill the goose that has been laying golden eggs for the past twenty years,“ Feiglin observed, “and it is not likely that Sarel will lose its monopoly so quickly. But our efforts to reveal the corruption are paying off and apparently, the medical cannabis rights will not be given to Sarel. That is a step in the right direction,” Feiglin concluded.